Over the past four decades, research on the natural history of HIV infection has described
how HIV wreaks havoc on human immunity and causes AIDS. HIV host genomic research …

The emergence of chronic disease complications in controlled HIV disease has changed the
landscape of HIV clinical care. HIV infection confers an increased cardiovascular disease …

Background With the aging of the population living with HIV, the absolute risk of
cardiovascular disease (CVD) is increasing. There is a need to further facilitate the …

The treatment of metabolic disease is becoming an increasingly important component of the
long-term management of patients with well controlled HIV on antiretroviral therapy (ART) …

In this paper, we propose privacy-enhancing technologies for medical tests and
personalized medicine methods that use patients' genomic data. Focusing on genetic …

The lives of individuals infected with HIV who have access to combination antiretroviral
therapy (cART) are substantially prolonged, which increases the risk of developing non …

Modern ART has now achieved the goal of maintaining HIV RNA suppression with minimum
drug-related toxicities. Indeed, in high-income settings, the main health issues in adult …

The overall purpose of these guidelines is to provide guidance on best clinical practice in
the treatment and management of adults with HIV infection on antiretroviral therapy (ART) …

Aims HIV-positive persons have increased cardiovascular event rates but data on the
prevalence of subclinical atherosclerosis compared with HIV-negative persons are not …

Objectives Abacavir's potential to cause cardiovascular disease (CVD) among people living
with HIV (PLWH) is debated. We conduct a systematic review and meta-analyses to assess …